SEACOAST PATHOLOGY INC NPI 1790996882

NPI Details

SEACOAST PATHOLOGY INC is a clinical medical laboratory in Exeter, NH. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. SEACOAST PATHOLOGY INC NPI is 1790996882. The provider is registered as an organization entity type.

The provider's business location address is:

1 HAMPTON RD
SUITE 208
EXETER, NH
ZIP 03833-848
Phone: (603) 778-8522
Fax: (603) 778-1602

The provider's authorized official is Michael C. Grattendick .
The authorized official title is Vice President and has the following contact phone number (561) 626-5512.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Detection test for candida species (yeast), direct probe technique (HCPCS:87480)
• Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Evaluation of fine needle aspirate with interpretation and report (HCPCS:88173)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
• Measurement of rna of bacteria in vaginal fluid specimen (HCPCS:81513)
• Pap test (HCPCS:88141)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
• Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)

The enumeration date for this NPI number is 5/24/2007 and was last updated on 3/23/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.